4th Quarter - Report
HOSPIRA, INC. for HOSPIRA INC
Firm
Client
Income
—
Expenses
$280,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Implementation of the Biologics Price Competition and Innovation Act (BPCIA)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIANA REED | — |
| WENDY SUSSMAN | — |
Medicare/Medicaid MMM
Issues related to integrating biosimilar medications into the Medicare and Medicaid programs; issues related to creating a new marketplace for biosimilar medications in the United States.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIANA REED | — |
| WENDY SUSSMAN | — |
Pharmacy PHA
Issues relating to opioid abuse and drug shortages; Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIANA REED | — |
| WENDY SUSSMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.